Phosphoric Acid Diethyl Ester Phenyl Ester

Phosphoric Acid Diethyl Ester Phenyl Ester

SCHEMBL133234

CCOP(=O)(OCC)Oc1ccccc1

nearest known ligand 0.72

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 P00915 2/20 0.59
CA2 P00918 2/20 0.59
BCHE P06276 1/20 0.59
ACHE P22303 1/20 0.59
L3MBTL1 Q9Y468 2/20 0.53
POLB P06746 2/20 0.51
MEN1 O00255 1/20 0.51
GAA P10253 1/20 0.51
KMT2A Q03164 1/20 0.51
NPSR1 Q6W5P4 1/20 0.50
KCNH2 Q12809 1/20 0.48
SRC P12931 1/20 0.48
TSHR P16473 1/20 0.48
TDP1 Q9NUW8 1/20 0.47
CA12 O43570 1/20 0.46
CA4 P22748 1/20 0.46
CA5A P35218 1/20 0.46
CA7 P43166 1/20 0.46
CA9 Q16790 1/20 0.46
CA5B Q9Y2D0 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Phosphoric Acid Diethyl Ester Phenyl Ester SCHEMBL29756498 0.98 CA1 (0.57) CA1CA2BCHEACHEL3MBTL1
SCHEMBL124095 0.96 CA1 (0.54) CA1CA2BCHEACHEL3MBTL1
SCHEMBL28546756 0.94 CA1 (0.53) CA1CA2BCHEACHEL3MBTL1
SCHEMBL11432841 0.90 CA1 (0.50) CA1CA2BCHEACHEL3MBTL1
SCHEMBL5026807 0.89 CA2 (0.70) CA1CA2BCHEACHEPOLB
SCHEMBL11179182 0.89 CA1 (0.49) CA1CA2BCHEACHEL3MBTL1
SCHEMBL29068406 0.89 CA1 (0.49) CA1CA2BCHEACHEL3MBTL1
SCHEMBL10784073 0.89 CA1 (0.57) CA1CA2BCHEACHEL3MBTL1
SCHEMBL38652182 0.88 CA1 (0.49) CA1CA2BCHEACHEL3MBTL1
SCHEMBL20704057 0.87 CYP3A4 (0.60) CA1CA2BCHEACHEL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 230 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260015372-A1 Organophosphorous Compounds and Uses Thereof JAL THERAPEUTICS LLC (US) 2026-01-15 US claimed
CN-119034812-A Catalyst composition, method for selectively hydrogenating conjugated diene latex, hydrogenated conjugated diene latex and application thereof 山东京博中聚新材料有限公司 2024-11-29 CN claimed
CN-117821150-B Drawing friction protection surface treatment composition with good lubricity, and preparation method and application thereof 东莞市颖兴金属表面处理材料有限公司 2024-10-25 CN claimed
CN-118146190-A New crystal form of cyantraniliprole, and preparation method and application thereof 南开大学 2024-06-07 CN claimed
WO-2024020507-A2 ORGANOPHOSPHOROUS COMPOUNDS AND USES THEREOF JAL THERAPEUTICS, LLC (US) 2024-01-25 WO claimed
CN-110612119-A Phospholipid ether (PLE) CAR T cell tumor targeting (CTCT) agents 西雅图儿童医院(DBA西雅图儿童研究所) 2019-12-24 CN claimed
WO-2018148224-A1 PHOSPHOLIPID ETHER (PLE) CAR T CELL TUMOR TARGETING (CTCT) AGENTS Seattle Children's Hospital (dba Seattle Children's Research Institute) (US) 2018-08-16 WO claimed
CN-107489047-A A kind of high-performance polypropylene plastic ties 界首市宏利塑料有限公司 2017-12-19 CN claimed
US-9139498-B2 Catalytical synthesis of hydrohalocarbons THE CHEMOURS COMPANY FC, LLC (US) 2015-09-22 US claimed
US-20140058141-A1 CATALYTICAL SYNTHESIS OF HYDROHALOCARBONS THE CHEMOURS COMPANY FC, LLC 2014-02-27 US claimed
WO-2012067872-A1 PROCESS FOR MAKING HYDROHALOCARBONS AND SELECTED COMPOUND E. I. DU PONT DE NEMOURS AND COMPANY (US) 2012-05-24 WO claimed
WO-2012067870-A1 PROCESS FOR MAKING HYDROHALOCARBONS AND SELECTED COMPOUNDS E. I. DU PONT DE NEMOURS AND COMPANY (US) 2012-05-24 WO claimed
CN-101812206-A Polyvinyl chloride plastisol composition and product prepared thereby DU PONT 2010-08-25 CN claimed
US-7723449-B2 Catalysts for synthesizing a polypropylene with a wide molecular weight distribution and use of the same CHANGCHUN INSTITUTE OF APPLIED CHEMISTRY CHINESE ACADEMY OF SCIENCES (CN) 2010-05-25 US claimed
EP-1973965-B1 NON-HALOGEN FLAME RETARDANT ADDITIVES FOR USE IN RIGID POLYURETHANE FOAM SUPRESTA LLC (US) 2009-08-26 EP claimed
US-20090156704-A1 Non-Halogen Flame Retardant Additives for Use in Rigid Polyurethane Foam ICL-IP AMERICA INC. 2009-06-18 US claimed
JP-2009522432-A 2009-06-11 JP claimed
US-20090023881-A1 Catalyst for synthesizing a polypropylene with a wide molecular weight distribution and use of the same CHANGCHUN INSTITUTE OF APPLIED CHEMISTRY CHINESE ACADEMY OF SCIENCES (CN) 2009-01-22 US claimed
EP-1973965-A1 NON-HALOGEN FLAME RETARDANT ADDITIVES FOR USE IN RIGID POLYURETHANE FOAM Supresta LLC (US) 2008-10-01 EP claimed
WO-2007081903-A1 NON-HALOGEN FLAME RETARDANT ADDITIVES FOR USE IN RIGID POLYURETHANE FOAM SUPRESTA LLC (US) 2007-07-19 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260015372-A1 Organophosphorous Compounds and Uses Thereof ACHE, BCHE, MUSK CA1 2847/4885CA2 2208/4885BCHE 2/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.